Although the onset of liver injury was mostly within three months in an international phase III trial, its exact timing remains unknown [1]. Among hepatic disorders, grade 3 or higher alanine aminotransferase (ALT) elevations were reported in 0.9% (1/222) and 0% (0/3) of Japanese patients [1]. The gene discussed is GPT; the disease is liver disorder.